Prior Authorization Criteria for Approval
PA applies to new starts only
Imiquimod 5% cream will be approved when the following is met:
- The patient has ONE of the following diagnoses:
- Actinic keratosis
OR - Superficial basal cell carcinoma
OR - External genital and/or perianal warts/condyloma acuminata
OR - Squamous cell carcinoma
OR - Basal cell carcinoma
OR - Another indication that is supported in CMS approved compendia for the requested medication
- Actinic keratosis
Length of Approval:
Actinic keratosis: 4 months
Superficial basal cell carcinoma: 2 months
External genital and/or perianal warts/condyloma acuminata: 4 months
Squamous cell carcinoma: 2 months
Basal cell carcinoma: 2 months
All other indications: 12 months
Blue Cross and Blue Shield of North Carolina does not discriminate on the basis of race, color, national origin, sex, age or disability in its health programs and activities. Learn more about our non-discrimination policy and no-cost services available to you.
Information in other languages: Español 中文 Tiếng Việt 한국어 Français العَرَبِيَّة Hmoob ру́сский Tagalog ગુજરાતી ភាសាខ្មែរ Deutsch हिन्दी ລາວ 日本語
© 2026 Blue Cross and Blue Shield of North Carolina. ®, SM Marks of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans. All other marks and names are property of their respective owners. Blue Cross and Blue Shield of North Carolina is an independent licensee of the Blue Cross and Blue Shield Association.